FitLife Brands, Inc. Common Stock (FTLF) Stock Price

FTLFStock

$9.79−47.61%52W

Market Cap$91.90M

P/E16.61x

PEG Ratio—

Div yield—

Beta0.05

FTLF Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-47.12%

Price vs S&P 500 (4W)-2.75%

VGM Score50.57

P/E Ratio (Annual)16.61x

P/CF (Annual)14.13x

Book Value / Share (Quarterly)$4.83

P/TBV (Annual)15.15x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)41.42%

Cash Flow / Share (Quarterly)$0.81

Price vs S&P 500 (YTD)-52.67%

Gross Margin (TTM)36.39%

Net Profit Margin (TTM)5.73%

EPS (TTM)$0.60

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$0.60

Revenue Growth (5Y)29.80%

EPS (Annual)$0.63

ROI (Annual)7.17%

Gross Margin (Annual)38.61%

Net Profit Margin (5Y Avg)13.30%

Cash / Share (Quarterly)$0.13

P/E Basic Excl Extra (TTM)17.43x

Revenue Growth QoQ (YoY)58.92%

EPS Growth (5Y)-20.04%

P/E Normalized (Annual)16.61x

ROA (Last FY)5.95%

Revenue Growth TTM (YoY)17.01%

EBITD / Share (TTM)$1.08

ROE (5Y Avg)22.17%

Operating Margin (TTM)10.23%

Cash Flow / Share (Annual)$0.79

P/B Ratio2.32x

P/B Ratio (Quarterly)2.94x

Net Income / Employee (Annual)$78,100

EV / Revenue (TTM)1.95x

Net Interest Coverage (TTM)5.61x

ROA (TTM)6.29%

EPS Growth QoQ (YoY)-15.30%

EV / EBITDA (TTM)13.46x

EPS Incl Extra (Annual)$0.63

Current Ratio (Annual)1.53x

Quick Ratio (Quarterly)0.43x

3-Month Avg Trading Volume0.03M

52-Week Price Return-47.61%

EV / Free Cash Flow (Annual)19.67x

P/E Incl Extra (TTM)17.43x

Revenue / Employee (TTM)$922,500

Tangible BV / Share (Quarterly)$1.56

P/S Ratio (Annual)1.29x

Asset Turnover (Annual)0.77x

52-Week High$20.98

Operating Margin (5Y Avg)18.15%

EPS Excl Extra (Annual)$0.63

Tangible BV CAGR (5Y)70.47%

26-Week Price Return-35.19%

Quick Ratio (Annual)0.48x

13-Week Price Return-7.16%

Total Debt / Equity (Annual)1.02x

Current Ratio (Quarterly)1.52x

Enterprise Value$145.52M

Revenue / Share Growth (5Y)10.93%

Asset Turnover (TTM)0.70x

Book Value / Share Growth (5Y)10.68%

Revenue / Employee (Annual)$1,005,700

Inventory Turnover (Annual)3.09x

Pretax Margin (Annual)10.10%

Cash / Share (Annual)$0.18

3-Month Return Std Dev60.24%

Gross Margin (5Y Avg)41.88%

Net Income / Employee (TTM)$74,400

EBITDA CAGR (5Y)18.67%

EBITDA Interim CAGR (5Y)10.55%

ROE (Last FY)14.50%

Net Interest Coverage (Annual)4.48x

EPS Basic Excl Extra (Annual)$0.63

P/FCF (TTM)13.87x

Receivables Turnover (TTM)14.27x

EV / Free Cash Flow (TTM)19.21x

Total Debt / Equity (Quarterly)0.92x

EPS Incl Extra (TTM)$0.60

Receivables Turnover (Annual)15.68x

ROI (TTM)7.65%

P/S Ratio (TTM)1.41x

Pretax Margin (5Y Avg)17.21%

Revenue / Share (Annual)$8.16

Tangible BV / Share (Annual)$1.07

Forward P/E10.19x

Free OCF CAGR (5Y)5.27%

Price vs S&P 500 (52W)-66.17%

P/E Ratio (TTM)17.43x

EPS Growth TTM (YoY)-32.36%

Year-to-Date Return-39.85%

5-Day Price Return-2.14%

EPS Normalized (Annual)$0.63

ROA (5Y Avg)14.65%

Net Profit Margin (Annual)7.77%

Month-to-Date Return-1.25%

Cash Flow / Share (TTM)$0.89

EBITD / Share (Annual)$1.05

EPS Growth (3Y)12.51%

Operating Margin (Annual)12.35%

LT Debt / Equity (Annual)0.88x

P/CF (TTM)13.84x

ROI (5Y Avg)17.72%

P/E Excl Extra (TTM)17.43x

LT Debt / Equity (Quarterly)0.78x

EPS Basic Excl Extra (TTM)$0.60

P/TBV (Quarterly)8.36x

P/B Ratio (Annual)3.50x

Inventory Turnover (TTM)3.37x

Pretax Margin (TTM)7.33%

Book Value / Share (Annual)$4.65

Price vs S&P 500 (13W)-9.11%

Net Margin Growth (5Y)-27.91%

Beta0.05x

P/FCF (Annual)14.21x

Revenue / Share (TTM)$7.48

ROE (TTM)14.03%

52-Week Low$8.67

vGradeB

gGradeC

mGradeD

vgmGradeC

FTLF Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	$0.20	$0.20	+2.56%(+$0.01)
Q1 2026	May 14, 2026	$0.13	$0.17	+36.00%(+$0.05)
Q4 2025	Apr 1, 2026	$0.18	$0.16	-11.11%(-$0.02)
Q3 2025	Nov 13, 2025	$0.29	$0.09	-68.97%(-$0.20)
Q2 2025	Aug 14, 2025	$0.17	$0.18	+2.86%(+$0.01)

FTLF Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$9.79
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$40.98
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	D	$5.50
TRLVTrulieve Cannabis Corp.	B	C	A	$11.82
CRONCronos Group Inc. Common Share	C	B	B	$3.38
GLASGlass House Brands Inc.	C	C	C	$9.88
TLRYTilray Brands, Inc. Common Stock	B	B	D	$4.59
CGCCanopy Growth Corporation Common Shares	B	C	D	$1.00
SNDLSundial Growers Inc. Common Shares	A	C	D	$1.35
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	$3.29
USNAUSANA Health Sciences Inc	B	D	D	$14.04
ACBAurora Cannabis Inc. Common Shares	B	D	C	$4.01
MDWDMediWound Ltd.	C	F	D	$12.66
BTMDBiote Corp. Class A Common Stock	A	D	D	$1.57
NAIINatural Alternatives International Inc.	A	C	D	$2.16
MTEXMannatech Inc.	B	D	B	$6.74
BONBon Natural Life Limited Class A Ordinary Shares	B	D	C	$1.14
AKANAkanda Corp. Common Shares	C	F	D	$3.89
IMCCIM Cannabis Corp. Common Shares	A	B	F	$3.41
SNYRSynergy CHC Corp. Common Stock	A	C	F	$0.10
MEHAFunctional Brands, Inc. Common Stock	A	C	D	$0.01
TRUUVanEck Utilities TruSector ETF	—	—	C	$23.37

About FitLife Brands, Inc. Common Stock

FitLife Brands Inc manufactures and sells nutritional supplements and health products under multiple brands including NDS, PMD, Siren Labs, Core Active, Metis Nutrition, Isatori, and Biogenetic Laboratories. The company's product portfolio spans sports nutrition, energy drinks, meal replacements, weight loss supplements, and natural and organic foods and personal care items. Revenue is generated from direct product sales to health-conscious consumers.